Publication | Open Access

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Tumor BiologyProgrammed Death-MedicineCell DeathBronchial NeoplasmDiminished EfficacyKras Mutation StatusCancer GeneticsRadiation OncologyCancer BiologyCell BiologyLung CancerCancer Research